{xtd_wp_head}
Skip to content
About
Technology
Innovators
Students
Industry

Market Overview

In the United States alone, more than 11.1 million people have contracted COVID-19. Managing the infection rate relies on symptom tracking of populations. However, most healthcare facilities, which are comprised of multiple providers serving diverse patient populations, do not have the capability to simultaneously monitor individuals and the population at large. This situation makes it difficult to formulate and initiate informed decisions about the safety measures needed to keep the infection rate low. To address this issue, Clemson University researchers have developed software that allows for collective symptom tracking of populations, giving healthcare practitioners both individual and population-level health data. As COVID-19 affects increasingly more populations, the relationship between symptoms and results will become more complex and difficult to analyze, making this software even more critical.
Jordon Gilmore
Nancy Meehan
2021-015

Applications:

COVID-19, Symptom Tracking, Software, Precision Health

Technical Summary:

This technology features an engaging patient interview in a conversational format that allows for individual and collective symptom tracking of populations. It provides a way for healthcare providers and administrators to quickly identify at-risk patients and advise them on appropriate precautions and treatment, while at the same time streamlining the monitoring and analysis process for patient populations. The modular format of the software gives administrators and supervising healthcare providers the ability to select the patient data and analytics profiles most relevant for their organizational needs.

Advantages:

• Provides a tool for healthcare practitioners to quickly identify at-risk individuals
• Can be utilized by electronic health record companies looking for applications to add to their current systems
• Allows for tracking on a multi-organizational level, a key distinction from other applications currently being developed

Download Printable PDF

Technology Overview

State of Development

Prototype

Category

Biotechnology

CURF Reference No.

2021-015

Inventors

Jordon Gilmore, Nancy Meehan, Jerome McClendon


For More Info, Contact:

Andy Bluvas

Technology Commercialization Officer bluvasa@clemson.edu

Contact

Contact

Get Started
Ready to Get Started?

Contact our team at CURF

Contact CURF